CV Sciences, Inc. (CVSI)

4.53
OTC Markets
Prev Close 4.70
Day Low/High 4.49 / 4.70
52 Wk Low/High 1.10 / 9.20
Exchange OTC Markets
Shares Outstanding 98.66B
Market Cap 463.69M
Div & Yield N.A. (N.A)

Latest News

Investors Should Be Cautious as CBD Products Go Mainstream

Investors Should Be Cautious as CBD Products Go Mainstream

The passage of the 2018 Farm Bill has ushered in an explosion of hemp-based cannabidiol (CBD) products.

Farm Bill Passes, and These Hemp Companies Will Be Big Winners

Farm Bill Passes, and These Hemp Companies Will Be Big Winners

Here are 5 hemp companies and 5 hemp states that will benefit the most.

CV Sciences CEO on How CBD is Being Regulated in the U.S.

CV Sciences CEO on How CBD is Being Regulated in the U.S.

CBD is legal in 50 states, but how is it being regulated?

DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against CV Sciences, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against CV Sciences, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CV Sciences, Inc.

Cannabis Stocks, Led by Tilray and IGC, Get Taken to the Woodshed

Cannabis Stocks, Led by Tilray and IGC, Get Taken to the Woodshed

Cannabis stocks are falling sharply on Monday.

CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In CV Sciences, Inc. To Contact The Firm

CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In CV Sciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CV Sciences, Inc.

India Globalization Drops 10% as Other Pot Stocks Gain on New Canada Law

India Globalization Drops 10% as Other Pot Stocks Gain on New Canada Law

The drop comes days after the company targeted a March roll out for an Alzheimer's product.

Investors Face Growing Opportunities and Challenges in Cannabis

Investors Face Growing Opportunities and Challenges in Cannabis

An expert panel points out the huge potential for cannabis across many consumer categories, along with the daunting challenge of picking investments.

CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In CV Sciences, Inc. To Contact The Firm

CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In CV Sciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CV Sciences, Inc.

CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In CV Sciences, Inc. To Contact The Firm

CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In CV Sciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CV Sciences, Inc.

7 Smart Ways to Invest in Cannabis Stocks and Not Get Burned

7 Smart Ways to Invest in Cannabis Stocks and Not Get Burned

There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.

CVSI NOTICE: Rosen Law Firm Reminds CV Sciences, Inc. Investors Of Important Deadline In Suit - CVSI

CVSI NOTICE: Rosen Law Firm Reminds CV Sciences, Inc. Investors Of Important Deadline In Suit - CVSI

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CV Sciences, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CV Sciences, Inc. - CVSI

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CV Sciences, Inc. - CVSI

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CV Sciences, Inc.

Bath Bombs and Muscle Creams: How Beauty Is Becoming the Fast Lane for Cannabis Growth

Bath Bombs and Muscle Creams: How Beauty Is Becoming the Fast Lane for Cannabis Growth

Medical marijuana may be facing regulatory hurdles across the U.S., but the beauty brands see a future in cannabis too big to ignore.

CV Sciences, Inc. Repays Installment Obligation On Convertible Debt

CV Sciences, Inc. Repays Installment Obligation On Convertible Debt

Company Avoids Dilution to Stockholders

CV Sciences, Inc. To Present And Exhibit As Silver Sponsor At Natural Products Expo West 2018 In Anaheim, California, March 7-11, 2018

CV Sciences, Inc. To Present And Exhibit As Silver Sponsor At Natural Products Expo West 2018 In Anaheim, California, March 7-11, 2018

Company enters its 3rd year sponsoring and exhibiting at the nation's largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product offerings

CV Sciences, Inc. To Exhibit And Present At The 2018 Integrative Health Symposium Annual Conference In New York, New York - February 22-24, 2018

CV Sciences, Inc. To Exhibit And Present At The 2018 Integrative Health Symposium Annual Conference In New York, New York - February 22-24, 2018

Company Continues Targeting the Broad Network of Healthcare Practitioners focused on Integrative and Nutritional Modalities

CV Sciences, Inc. Repays Installment Obligation On Convertible Debt

CV Sciences, Inc. Repays Installment Obligation On Convertible Debt

Company Avoids Dilution to Stockholders

CV Sciences, Inc. To Exhibit At The 25th Annual World Congress On Anti-Aging Medicine In Las Vegas, NV - December 14-16th, 2017

CV Sciences, Inc. To Exhibit At The 25th Annual World Congress On Anti-Aging Medicine In Las Vegas, NV - December 14-16th, 2017

Company Continues to Expand Its Distribution Network to Health Care Practitioners focused on Integrative and Nutritional Modalities

CV Sciences, Inc. Repays Installment Obligation On Convertible Debt

CV Sciences, Inc. Repays Installment Obligation On Convertible Debt

Company Avoids Dilution to Stockholders

CV Sciences, Inc. Announces Its Silver Sponsorship Of SOHO Expo In Orlando, FL - December 1-3, 2017

CV Sciences, Inc. Announces Its Silver Sponsorship Of SOHO Expo In Orlando, FL - December 1-3, 2017

Company enters its 3rd year exhibiting its industry-dominating brand, PlusCBD Oil™ at the Southeastern Regional Natural Health Retailer Conference and Expo.

CV Sciences, Inc. Named One Of North America's Fastest Growing Companies On Deloitte's 2017 Technology Fast 500™

CV Sciences, Inc. Named One Of North America's Fastest Growing Companies On Deloitte's 2017 Technology Fast 500™

Award recognizes 500 of the fastest growing companies in North America from 2013 to 2016